Breaking News

Patheon Asks OSC To Review JLL Offer

The Special Committee of Independent Directors of Patheon requested that the Ontario Securities Commission (OSC) review the legality of the unsolicited offer by JLL Patheon Holdings LLC to acquire outstanding restricted voting shares of Patheon not owned

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The Special Committee of Independent Directors of Patheon requested that the Ontario Securities Commission (OSC) review the legality of the unsolicited offer by JLL Patheon Holdings LLC to acquire outstanding restricted voting shares of Patheon not owned by JLL or its affiliates. The committee contends the offer violates securities laws in that all Patheon shareholders were not treated equally, and that the offer lacks required information. The OSC can exercise its power to cease trade the JL...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters